Trial Profile
Treatment of Pituitary Tumors with Temozolomide: A Case Series
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2014
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Pituitary tumours
- Focus Therapeutic Use
- 15 Sep 2014 New trial record